myopathies
DESCRIPTION
MYOPATHIES A SPECIAL AND SEPERATE ENTITY WITH SPECIFIC FEATURES IN EACH DISORDER MAKING US EASY FOR DIAGNOSIS,CONFIRMATION BY MUSCLE BIOPSY.THE SEMINAR WAS PRSENTED ON 06/07/2011...AT 09.00AM HAVE A LOOK ..AND COMMENT..WITHOUT BIAS..TRANSCRIPT
MYOPATHIES
DR.PRAVEENNAGULA
ETIENNE JULES MAREY
HARVEY CUSHING
UNVERRICHT
ERNST LEBERECHT WAGNER
Basic muscle anatomy.physiology
INTRODUCTION MYOPATHY means primary skeletal muscle dysfunction. WASTING--- related to muscle MYALGIA– muscle pain FIBRILLATIONS - when muscle fibers lose contact with their
innervating axon producing a spontaneous action potential, "fibrillation potential" that results in the muscle fiber's contraction. not visible under the skin and are detectable through needle electromyography (EMG) and ultrasound.-pathological
FASCICULATIONS – visible spontaneuos contractions. SPASM/CRAMP – sudden PAINFUL involuntary contraction of
muscle TONE – continuous and partial contraction of the muscles AT
REST.resting muscle tension CLONUS –series of involuntary muscle contractions. MYOKYMIA – INVOLUNTARY ,groups of fasciculations –continuous
undualtions of muscle.
NERVOUS SYSTEM EXAMINATION In motor unit points in favour of myopathy : Muscle appearance – wasting ,atrophy (neurogenic) ABSENT fasciculations (+Denervation) Tenderness on palpation Tone –normal ,decreased in advanced cases. Distribution of weakness –proximal,distal (distal myopathies)
Pronator drift test Tendon reflexes – normal /hypoactive in adv.cases Babinski sign negative SENSORY system is normal. GAIT – lordosis on stance,increased on toe walking
Waddling gait – b/l pelvic girdle weakness Genu recurvatum –quadriceps weakness.
TYPE OF WEAKNESSINTERMITTENT MUSCLE WEAKNESS PERSISTENT WEAKNESS
SYMMETRIC
Atrophy asymmetric muscle weakness
Forearm flexors and quadriceps –PATHOGNOMONIC OF IBM
Dropped head syndrome
MG,ALS
Nemaline myopathy
Hyperparathyroidism
Focal myositis
IBM
APPROACH OF A PATIENT WITH INTERMITTENT WEAKNESS
Approach to a patient with PERSISTENT WEAKNESS
ONLY PTOSIS
MD
NEMALINE
NO PTOSIS
HYPERTHYROIDISM
Based on other complaintsFATIGUE Diff from asthenia
NMJ GLYCOLYSISLIPID ABNORMALITIES
MITOCHONDRIAL MYOPATHYCHRONIC MYOPATHY
MYALGIANO MUSCLE WEAKNESSFIBROMYALGIA
MYOFASCIAL SYN.
PMR,TEMPORAL ARTERITIS
MUSCLE WEAKNESSLOCAL -TRAUMA
CRAMPS +NMJDMD
MUSCLE CONTRACTUREGLYCOLYTICEMD
STIFFNESS
INFLAMMATION OF JOINTS
STIFFPERSON SYNDROME
NEUROMYOTONIA
•LIMB GIRDLE MUSCULAR DYSTOPHIES -
MUSCLE HYPERTROPHY
•DUCHENNE MUSCULAR DYSTROPHY
PSEUDOHYPERTROPHY
•HUMERAL MUSCLES - FSCHD•DYSFERLINOPATHIES -GASTROCNEMIUSATROPHY
EMG –assess the function of type I fibersnormal in steroid,disuse atrophy
EMG
IRRITABILITY ON NEEDLE PLACEMENT
INFLAMMATORY MYOPAT
HIESTOXIC
MYOPATHIES
DYSTROPHIESDIVE
BOMBER SIGNMYOTO
NIC MYOPAT
HY
NO IRRITABILITY
METABOLICMUSCULAR
DYSTROPHIESENDOCRINE
SHORT DURATIONSMALL AMPLITUDE
POLYPHASIC MOTOR UNIT ACTION POTENTIALS
NORMAL FIRING PATTER
N MYOPAT
HIES
FASTER FIRING NEUROGENIC
CAUSES
CLASSIFICATION 1.INFLAMMATORY /INFECTIOUS MYOPATHIES 2.CONGENITAL DISTAL MYOPATHIES 3.DISORDERS OF MUSCLE MEMBRANE EXCITABILITY 4.DRUG INDUCED/TOXIN INDUCED MYOPATHY 5.METABOLIC MYOPATHY 6.ENDOCRINE MYOPATHY 7.CRITICAL ILLNESS MYOPATHY 8.MITOCHONDRIAL MYOPATHIES 9.MUSCULAR DYSTROPHIES. 10.MISCELLANEOUS
INFLAMMATORY MYOPATIHES Largest group of acquired and potentially treatable causes of
skeletal muscle weakness . POLYMYOSITIS (PM) DERMATOMYOSITIS (DM) INCLUSION BODY MYOSITIS (IBM) 1 :1,00,000 PM – as alone is a rare disease affecting ADULTS. DM – affects both children,adults W>M IBM – M:F –3:1 ,caucasians,>50yrs.
PATHOGENESIS Autoimmune etiology - assosciation with other autoimmune
CTD ,various Auto Ab, MHC ,T CELL myotoxicity,complement, response to immunotherapy.
AUTOANTIBODIES AND IMMUNOGENETICS: 20% cases – ANA,anti cytoplasmic antigens Anticytoplasmic – anti RNP(anti synthetase), Anti jo 1 – 75% cases -80% assosciation with ILD. Anti Jo 1 –ILD ,RP,non erosive arthritis,MHCDR3,DRw52. DRB1 *0301,DQB1*0201 --- 75% PM,IBM DQA1*0501 –juvenile DM
IMMUNOPATHOGENIC MECHANISMS
DERMATOMYOSITIS: humoral immune mechanisms – microangiopathy. Endomysial inflammatory infiltrates -B cells auto AB -- complement pathway – C5b-9 membranolytic
complex- release of proinflammatory cytokines – VCAM1,ICAM 1 on endothelial cells – migration of lymphoid cells to perimysial and endomysial spaces---necrosis,microinfarcts.
Remaining capillaries dilated due to ischemia Perifascicular atrophy due to endofascicular hypoperfusion –
periphery of muscle fascicles.
IMMUNOPATHOGENIC MECHANISMS
POLYMYOSITIS,IBM : T cell mediated cytotoxicity CD8 T cells,macrophages –invade and destroy MHC 1 muscle
fibres(absent usually ) CD8/MHC 1 complex is characteristic of PM,IBM These cells have perforin,granzyme granules –myonecrosis. Antigen driven T cell response (auto AB in DM ) Antigens – endogenous (muscle),exogenous (viral) Co stimulatory molecules are upregulated .
ROLE OF NON IMMUNE FACTORS IBM : Degenerative process in addition to autoimmune process. B amyloid deposits within vacuolated muscle fibres,cyto ox –
ve mitochondria. Amyloid is APP,chymotrypsin,apoE,tau ?directly pathogenic /secondary MHC I upregulation – ER stress – accumulation of misfolded
glycoproteins ,NFkB –cytokine activation .
Association with viral infections Coxsackie,influenza,paramyxoviruses,mumps,CMV,EBV. Autoimmune myositis in coxsackie virus Molecular mimicry of Anti RNAsynthetase and genomic RNA . Best evidence of viral connection in PM,IBM –retroviruses. HIV,HTLV 1 – PM,IBM May be the initial manifestation or later of viral infection. Retroviral antigens –endomyosial macrophages ,but not in
muscle fibres. AZT induced myopathy –mitochondrial – ragged red fibres. AZT inhibits gamma DNA polymerase.
Clinical featuresIn general : PROGRESSIVE AND SYMMETRIC MUSCLE weakness (IBM –
asymmetric). Increasing difficulty with tasks – getting up from chair,climbing
steps,lifting objects,combing hair. Occular muscles are spared –even in advanced ,untreated
cases –if involved ? Diagnosis Head drop sign dysphagia Respiratory muscles involved in advanced cases. Muscle wasting in untreated cases . Sensation always normal . DTR preserved.
POLYMYOSITIS Subacute inflammatory myopathy affecting adults,rarely
children. Facial muscles are unaffected Diagnosis by exclusion. As an isolated entity it is rare. Commonly occurs in assosc.
With systemic autoimmune disease ,viral,bacterial. Drugs –AZT,D penicillamine
Who DONOT Have
1.Rash
2. EOM,facial muscles
3.Family H/O NMD
4.h/o myotoxic drugs,toxins
5.endocrinopathy
6.Neurogenic disease
7.Muscular dystrophy
8.Bicohemical disorder
9.IBM
DERMATOMYOSITIS Characteristic rash accompanying/preceding muscle weakness. –
increased photosensitivity Blue purple discoloration on the upper eyelids with edema.
(heliotrope rash) A flat red rash on the face and upper trunk. Erythema of the knuckles with a raised violaceous scaly eruption –
gottron’s sign . Erythematous rash on anterior chest – V sign. Back and shoulders – shawl sign . Dilated capillary loops at the base of the finger nails. Mechanic’s hands –irregular dirty horizontal lnies on the palmar
surface of fingers. Muscle tenderness,myalgia –connective tissue disease. Dermatomyositis sine myositis – muscle strength normal Perivascular perimysial inflammation
INCLUSION BODY MYOSITIS >50 yrs of age,most common inflammatory myopathy. Often misdiagnosed as PM Suspected when doesnot respond to therapy. Weakness and atrophy of distal muscles,foot extensors,deep
finger flexors –all cases –clue to early diagnosis. Fine motor movements –affected early Falling is common – quadriceps –buckling of knees. DTR –depressed in presence of atrophy . Dysphagia -60% cases Slow and steady progression Assisted devices required
Familial IBM 20 % CASES -systemic autoimmune or connective tissue
disease. Familial IBM Hereditary IBM - heterogenous group of recessive,dominant
inherited syndromes,non inflammatory May spare the quadriceps –iranian JEWS Chromosome 9p1 Mutations in the UDP – N acetylglucosamine 2- epimerase n –
acetylmannosamine kinase GNE gene.
Associated clinical findings EXTRAMUSCULAR MANIFESTATIONS: Systemic symptoms --- fever,malaise -- CTD. Joint contractures –DM in children Dysphagia ,GIabn – DM ,IBM Cardiac disturbances –arryhthmias,DCM,CCF Pulmonary dysfunction – ILD,drug induced – t RNA ab – 10% Subcutaneous calcifications –DM Arthralgias,deforming arthropathy – anti jo1 ab MALIGNANCIES – DM>PM,IBM Nasopharyngeal cancer in india Ovarian,breast,melanoma ,colon,NHL OVERLAP SYNDROMES – DM – SSc,PM – RA ,sjogren’s,SLE Anti PM/Scl - overlap syndrome of DM.
DIFFERENTIAL DIAGNOSIS SUBACUTE OR PROGRESSIVE MUSCLE WEAKNESS :
SPINAL MUSCULAR ATROPHY,ALS UMN signs ,denervation signs on EMG
MUSCULAR DYSTROPHIES – progress over years ,rarely present >30 yrs. RAPIDLY ADVANCING MUSCULAR dystrophy –fascio
scapulohumeral,dysferlin –inflammatory cell infiltration early. Trial of glucocorticoids,MHC/CD8
MYOPHOSPHORYLASE /ACID MALTASE deficiency ENDOCRINE TUMOR ASSOCIATED CACHEXIA LAMBERT EATON SYNDROME,MG
ACUTE MUSCLE WEAKNESS: GBS Transverse myelitis Poliomyelitis Myophosphorylase deficiency PARASITIC polymyositis. Tropical polymyositis –s.aureus Periodic paralysis Chronic ALCOHOLICS
MYOFASCITIS – skin induration -eosinophilic myofascitis NECROTIZING MYOSITIS – CK is high.ILD,CMP,anti SRP. DRUG INDUCED – d penicillamine Weakness due to muscle pain ,tenderness –PMR -type ii muscle
fibres,CFS –biopsy normal.
LAB INVESTIGATIONS 1.SERUM MUSCLE ENZYMES :most sensitive CK . Parallels disease activity (active -50 fold) Normal when CTD +PM,DM serumGOA,GPT,LDH,aldolase – elevated. 2.EMG – short duration,low amplitude polyphasic units on
voluntary activation,spontaneuous fibrillations,positive sharp waves.
Mixed potentials –IBM Identifies acute/chronic,excludes nuerogenic 3.MRI –muscle biopsy 4.muscle biopsy – definitive test Inflammation is the hallmark
Muscle biopsy POLYMYOSITIS – Primary – T cell infiltrates (endomyosial) surround healthy
muscle fibers- phagocytosis. CD8/MHC 1 –confirms the diagnosis. Alkaline phosphatase –react positively. DERMATOMYOSITIS – perivascular,interfascicular septae Intramuscular BV – endothelial hyperplasia Wedge shaped microinfarcts. Presence of perifascicular atrophy is diagnostic of DM in
absence of inflammation also. INCLUSION BODY MYOSITIS – rimmed vacuoles,fat
repalcement,ragged red fibres,amyloid deposits.
TREATMENT GOAL : improve muscle strength,ameliorate extramuscular
manifestations. Discontinue the drugs if after trial no improvement of muscle
strength. 1.GLUCOCORTICOIDS :oral prednisolone –high doses –
1mg/kg/day – 3-4 weeks,taper later 10 weeks – 1mg/kg every other day.
Lowest possible dose to be used. Efficacy by third month DM > PM in response. Steroid myopathy – increased weakness –2- 8 weeks.
Treatment cont… 2.IMMUNOSUPPRESSIVE THERAPY : 75% patients ultimately require. A.AZATHIOPRINE : 3mg/kg/day B.MTX : 7.5 mg weekly for the first 3 weeks -2.5mg/wk- 25 mg/wk --- MTX
pneumonitis. C.mycophenolate MOFETIL – 2.5 mg/d D.rituximab - IN DM E.CYCLOSPORINE – inconsistent benefit F.TACROLIMUS - PM difficult cases. 3.IMMUNOMODULATION: IVIg in refractory DM -short term benefit 2g/kg over 2-5 days /course PLASMAPHERESIS,LEUKOPHERESIS - NOT EFFECTIVE IN PM,DM
EMPIRICAL APPROACH IN TREATMENT
STEP 1 – HIGH DOSE PREDNISOLONE
HIGH DOSE PREDNISOLONE
AZATHIOPRINE,MYCOPHENOLATE,MTX
IVIG
Based on pt AGE,DISABILITY ,TOLERANCE – RITUXIMAB,CYCLOSPORINE,CYCLOPHOSPHAMIDE,TACROLIMUS(ILD)
NO RESPONSE TO TREATMENT IBM or metabolic myopathy,muscular dystrophy,endocrinopathy. Repeat muscle biopsy Calcinosis of DM –difficult to treat IBM –resistant to immunosupressive therapy Drugs not to be withdrawn IVIg and prednisolone – not effective
PROGNOSIS -5 yr surivival – 95%,10 yr -85% Death –pulmonary,cardiac Worse prognosis – older,severe mainfestations at prsentation DM responds favorably than PM,IBM IBM –least favorable prognosis.
ENDOCRINE MYOPATHIES Muscle fatigue is more common than true weakness. Serum CK LEVELS are normal. Muscle histology –atrophy rather than destruction. All respond to treatment THYROID DISORDERS: HYPOTHYROIDISM –proximal muscle weakness-1/3 Slow muscle contraction and relaxation -25% cases. Relaxation phase prolonged –ankle,biceps reflex Serum CK 10 times normal,EMG normal Muscle may be enlarged?,biopsy –no features
HYPERTHYROIDISM: Proximal muscle weakness,atrophy of
muscles. DTRs enhanced response. Bulbar,esophageal,respiratory muscles
affected. Fasciculations+DTRs –ALS misdiagnosis Acquired hypokalemic periodic
paralysis,MG,graves ophthalmopathy Serum CK levels are normal EMG is normal Muscle histology –atrophy of muscles
THYROID MYOPATHY
1.CHRONIC THYROTOXIC MYOPATHY
2.EXOPHTHALMOOPTHALMOPLEGIA
3.THYROTOXIC HYPOKALEMIC PERIODIC PARALYSIS
4.MYASTHENIA GRAVIS ASS WITH HYT.
5.HYPOTHYROID MYOPATHY
CHRONIC THYROTOXIC MYOPATHY – nodular goitre. Men>women. Basedow paraplegia. Atrophy – shoulder and hand muscles. Tremor twitches but not fasciculations GRAVES OPTHALMOPATHY- IR,MR,strabismus,diplopia Infiltrative opthalmopathy THYROTOXIC HPP- not familial,few hours,adult life. Hypothyroidism aggravates the weakness of MG Kocher -debre semelgaine syndrome,hoffmann syndrome
Adrenal disorders Most commonly diagnosed endocrine muscle disease. Proximal muscle weakness. Muscle wasting –striking feature+ cushingoid facies Type 2b fibres atrophy on histology Potassium depletion –CONN’S syndrome –NM complications. Serum CK LEVELS ELEVATED,vacuoles on biopsy. Vitamin D deficiency Parathyroid disorders –hypo,hyper PITUITARY DISORDERS DIABETES MELLITUS—THIGH muscles,pain tenderness in thigh Hard indurated muscle,vastus lateralis
CRITICAL ILLNESS MYOPATHY Acute quadriplegic myopathy/acute steroid myopathy In cases of severe asthma ,sepsis and shock. Neuromuscular blocking agents in 80% cases. High doses of corticosteroids 1mg/kg ,pancuronium -500-4,000 mg Difficulty in weaning from the ventilator Tendon relfexes are normal- diminished –polyneuropathy Serum CK levels elevated. EMG –MYOPATHY.type 2 fibers vacuolation. Striking loss of myosin filaments Severe cases– myoglobinuria,renal failure. Denervation of muscles –increase in glucocorticoid receptors Recovery over 6- 12 weeks
Neuromuscu
lar blocki
ng agents
Muscle
denervation -
Increase in the glucocorticoid recept
ors
Myosin
filaments loss
CARCINOMATOUS MYOPATHY Syndromes of NMJ – LAMBERT EATON SYNDROME,MG Syndromes of muscle – polymyositis /dermatomyositis,acute
necrotizing myopathy. ACUTE NECROTIZING MYOPATHY-rhabdomyolysis Painful myopathy Necrosis of muscle– raised CK,myoglobinuria Urine is cola coloured . Detected by radioimmunoassay Alkalinization of urine –nahco3 Mannitol,diuretics,IV fluids
DRUG INDUCED MYOPATHY MYOPATHY FROM LIPID LOWERING AGENTS GLUCOCORTICOID RELATED MYOPATHIES MYOPATHY OF NON DEPOLARIZING NEUROMUSCULAR BLOCKING
AGENTS DRUG INDUCED MITOCHONDRIAL MYOPATHY DRUGS OF ABUSE AND RELATED MYOPATHY DRUG INDUCED AUTOIMMUNE MYOPATHIES OTHER
• FIBRATES ,HMG COA ,NIACIN,EZETIMIBE• MYALGIA,MUSCLE TENDERNESS.• MUSCLE PAIN RELATED TO EXERCISE• RHABDOMYOLYSIS,MYOGLOBINURIA• ELEVTED CK LEVELS –TOXICITY – 3 TIMES – STOP THE DRUG• MYOPATHIC EMG-MUSCLE NECROSIS ON BIOPSY• IMPROVEMENT –SEVERAL WEEKS• NO RESPONSE – IMMUNE MEDIATED MYOPATHY-
GLUCOCORTICOIDS
LIPID LOWERING AGENTS
• HIGH DOSE IV GLUCOCORTICOIDS• >30 MG/DAY USE OF PREDNISOLONE• FLUORINATED GLUCOCORTICOIDS -TRIAMCINOLONE• SERUM CK NORMAL IN CHRONIC CASES• LOSS OF MYOSIN IN ACUTE ONSET.• RECOVERY SLOW IN ACUTE QUADRIPLEGIC MYOPATHY
GLUCOCORTICOID
MYOPATHIES
• DRUG RELATED INFLAMMATORY OR ANTIBODY MEDIATED
• WILSON’S,SCLERODERMA,RA,PBC• DRUG INDUCED POLYMYOSITIS -1%• MYASTHENIA GRAVIS – 7%• IMPROVE ON DRUG WITHDRAWAL.
D –PENICILLA
MINE
DISORDERS OF MUSCLE MEMBRANE EXCITABILITY• ADOLESCENCE,M>W,HIGH CARB DIET,REST AFTER
EXERCISE,CARDIAC ARRYHTHMIAS• TYPE 1 –AD,CALCIA3 GENE,10% TYPE 2 –SCN4• RX—ORAL KCL -0.2-0.4MMOL/KG EVERY 30 MIN(,MANNITOL)• LOW CARB,LOW SODIUM DIET,ACETAZOLAMIDE MAY ABOLISH
ATTACKS(NT IN TYPE2)
CALCIUM CHANNEL –HYPOKALEMIC
PERIODIC PARALYSIS
• MISNOMER – AD IN INHERITANCE• PROXIMAL MUSCLES ,BULBAR ARE SPARED.• MYOTONIA WITHOUT WEAKNESS –COLD STIFFNESS• LESS VACUOLES,MORE PERIPHERAL• ACETAZOLAMIDE,MEXILITINE
SODIUM CHANNEL –HYPERKALEMIC
PERIODIC PARALYSIS
• MYOTONIA WORSENS WITH MUSCULAR ACTIVITY• SENSORY,MOTOR NERVE CONDUCTION STUDIES ARE NORMAL• MYOTONIC DISCHARGES DISAPPEAR ON COOLING• AD,SODIUM CHANNEL• INCREASED CARBOHYDRATE IN THE DIET,MEXILITENE,THIAZIDE
DIURETICS
SODIUM CHANNEL PARAMYOTONIA
CONGENITA
POTASSIUM CHANNEL DISORDERS: 1.ANDERSEN TAWIL SYNDROME: Episodic weakness,dysmorphic features. cardiac arrythmias are life threatening. autosomal dominant –kir 2.1 gene Acetazolamide CHLORIDE CHANNEL DISORDERS: AD –THOMSEN’S DISEASE AR – BEKER’S DISEASE Myotonia worsened by cold,improved by activity Muscle strength normal in thomson’s Quinine,mexiletine,phenytoin.
DISTAL MYOPATHIES
Late onset,>40 yrsDominantly
inherited
WELANDER
Markesbery - Griggs
Udd ,tibial muscular
dystrophy
WELANDER MYOPATHY
WRIST ,FINGER EXTENSORS
•DOMINANT,TIBIAL WEAKNESS•CHILDHOOD IN ONSET•RIMMED VACUOLES ON BIOPSY
LAING DISTAL MYOPATHY
•AR inheritance.•NONAKA - -- ANTERIOR TIBIAL WEAKNESS•MIYOSHI – GASTROCNEMIUS.,ELEV.CK,ABSENT DYSFERLIN
NONAKA DISTAL,MIYOSH
I MYOPATHY
•AD/AR,CLINCALLY HETEROGENOUS•MYOTONIC DISCHARGES ON EMG•DENSE INCLUSION ON BIOPSY,DESMIN
MYOFIBRILLAR MYOPATHY
****LIMITED TO SKELETAL MUSCLES
CONGENITAL MYOPATHIES Specific histochemical and structural abn in muscle.
Central core disease
Breech presentation
Legs>armsCHD,scoliosis,pes cavus
Non progressiveSuspectible to malignant hyperthermia
CPK NORMAL CORES ON BIOPSY DEVOID OF
OXIDATIVE ENZYMES
CENTRONUCLEAR MYOPATHY
MARFANOID HABITUS
PROGRESSIVE EXTERNAL
OPHTHALOMPLEGIA,EOM WEAKNESS
CMT 2 SOMETIMESXp28
MYOTUBULARINArR –CHILDHOOD
NO SPECIFIC TREATMENT
METABOLIC MYOPATHIES
Ppted by brief
bursts of high
intensity exercise
Warm up exercise
helpful in mc ardles’s
diseaseHemolytic
anemia seen with
phosphofructokinase deficiency
Phosphoglycerate kniase –mental
retardation,Forear
m exercise
test
• Infantile form most common• Glycogen accumulation occurs in neurons• Childhood form –muscular dystrophy,only heart • Heart and liver not involved in
adult ,resp .failure
Acid maltase deficiency (pompe’s
disease)
• Slowly progressive• Diagnosed in infancy with hypotonia,hepatomegaly• hypoglycemia
Debranching enzyme deficiency
Type III glycogenosis
• Rare AND FATAL • HEPATOMEGALY• SKELETAL MUSCLE MANIFESTATIONS ARE MINOR
Branching enzyme deficiency
Type IV glycogenosis
MYOPHOSPHORYLASE DEFICIENCY(TYPE V)
PHOSPHOFRUCTOKINASE (TYPE VII)
BETA ENOLASE DEFICIENCY
Lipid abn myopathiesCarnitine
Palmiotyl transferase deficiency
Mc cause of recurrent myoglobinuria
Muscle pain only after the limit exceeded.
A normal rise in venous lactate on forearm exercise test
CPT II deficiency more common in men than womenHigh carb diet
MITOCHONDRIAL MYOPATHIES TERM RAGGED RED FIBRES –ABNORMAL MITOCHONDRIA ON MODIFIED
TRCIHROME STAIN . Mitochondria are enlarged,bizarrely shaped,crystalline inclusions Most common is CPEO >50% cases of mitochondrial myopathies.
KEARNS SAYRE SYNDROMEONSET<20 YRS,CPEO,PIGMENTARY RETINOPATHY PLUS
CHB,CSF PROTEIN >1 G/L,CERBELLAR ATAXIA
DEATH DUE TO HEART BLOCK -20%
ENDOCRINE ABN ARE COMMON –DIABETES MELLITUS -13%
MENTAL RETARDATION ,DEMENTIA
SERUM CK LEVLES NORMAL,SERUM LACTATE AND PYRUVATE LEVELS ELEVATED
MELAS
MOST COMMON MITOCHONDRIAL ENCEPHALOMYOPATHY
NO STRICT VASCULAR DISTRIBUTION-STROKE LIKE
STROKE <40 YRS AGE
DEMENTIA,BEDRIDDEN,FATAL STATE
SERUM LACTIC ACID ELEVATED
T RNA MUTATIONS -LETHAL
TYPE I FIBER ATPASE STAIN
W H I T E T R I C H R O M E S TA I N
Pure myopathy syndromes Affects only the muscle Recurrent myoglobinuria without fixed weakness and thus
resemble a glycogen storage or CPT deficiency. MITOCHONDRIAL DNA DEPLETION MYOPATHY : Clinically indistinguishgable from muscular dystrophy. Simulates DMD Seizures,CMP may be present. Serum CK 20-30 times normal,EMG –ragged red fibres. AR condition TK2 gene mutation 16 q22—supplies deoxyribonucleotides.
MISCELLANEOUS NEUROMYOTONIA –CONTINUOUS MUSCLE FIBER ACTIVITY. Hyperexcitability of terminal motor neuron plates. Rippling of muscle fibers – myokymia –main clinical sign. Walking is laborious –armadillo syndrome. Muscle activity during sleep. Curare abolishes. ISAAC syndrome
TRIALS 827 STUDIES ON MYOPATHIES MOLECULAR AND GENETIC STUDIES OF CONGENITAL MYOPATHIES. PHARMACOKINETIC STUDY ON N ACETYL NEURAMINIC ACID CHARACTERIZATION OF IBM WITH PAGET’S,FTD IS MYOPATHY PART OF STATIN THERAPY –IMPOSTER 16 STEM CELL TRANSPLANTATION IN IDIOPATHIC INFLAMMATORY
MYOPATHY DISORDERS ANAKINRA IN MYOSITIS THE EFFECT OF STATINS ON MUSCLE PERFORMANCE –STOMP STUDY METHIMAZOLE FOR DERMATOMYOSITIS ARIMOCOLOL IN SPORADIC INCLUSION BODY MYOSITIS LOG ON TO www.clinicaltrials.gov
TAKE HOME MESSAGE MYOPATHIES need to be categorised based on the pattern of
weakness intermittent,persistent. Usually present as proximal muscle weakness. The clinical examination reveals wasting>atrophy,DTR being normal. Laboratory wise raised CK levels normally. Confirmatory diagnosis by MUSCLE BIOPSY .EMG –normal. POLYMYOSITIS is usually seen in assosciation with other
disorders .diagnosis by exclusion. DERMATOMYOSITIS responds well to treatment. IBM can be misdiagnosed as PM Drug induced myopathy --- check the list for statins,steroids. Critical illness myopathy,neuropathy –increasing entity. Congenital distal myopathies,mitochondrial to be considered in D.D
THANK YOU